Abstract

The aim of this retrospective clinical study was to assess the clinical outcomes of temporomandibular joint (TMJ) arthroscopy in patients who presented with category 1 normal joints. The null hypothesis being tested was that patients with normal joints do not respond to TMJ arthroscopy. The clinical records of 116 patients who had undergone TMJ arthroscopy by the author from 2010 to 2013 were retrieved and individually analysed for inclusion in this retrospective, cohort clinical study. The inclusion criteria used to select patients for this study were those who had arthroscopically proven category 1 normal joints, free of intra-articular pathology. Of the 14 patients who were found to have normal joints, only 10 could be contacted for a follow-up survey. Despite the fact that all patients were informed that no joint pathology was found, six out of the 10 patients reported improvement in their temporomandibular disorder (TMD) symptoms that lasted for more than 6 months following TMJ arthroscopy. The results of this investigation indicate that we can reject the null hypothesis, and that patients with normal TMJs do indeed respond to TMJ arthroscopy. What this limited study has highlighted is the pervasive effects of the placebo that all surgeons need to keep in mind when formulating treatment plans for patients with TMD.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.